Effect of pamidronate on the action of catecholamines on blood pressure in the marrow cavity of long bones in rats with prednisolone-induced osteoporosis.
Journal Title: Pharmacological Reports - Year 2007, Vol 59, Issue 1
Abstract
Pamidronate is a representative of bisphosphonates, which are effectively used in the treatment of bone diseases. Although a number of properties of pamidronate have been recognized which influence the metabolic process in bones, the issue of the effect of bisphosphonates on the function of blood circulation and autonomic nervous system in osteoporotic bones remains open. In order to clarify this problem, the present study concentrated on the effects of pamidronate on catecholamine action on blood pressure in the marrow cavity in rats with prednisolone-induced osteoporosis. The animals were divided into 3 groups: I - control rats; II - rats which were given prednisolone at the dose of 5 mg/kg, im, for 3 weeks; III - rats which were given prednisolone at the dose of 5 mg/kg, im and pamidronate at the dose of 3 mg/kg, sc together, for 3 weeks. The experiments demonstrated that rats with prednisolone-induced osteoporosis displayed a decreased blood pressure in the marrow cavity. In addition, a disordered action of catecholamines (norepinephrine and epinephrine) on blood pressure in the marrow cavity of osteoporotic bone was observed. Pamidronate administration in osteoporotic rats resulted in smaller increases in the blood pressure caused by norepinephrine and epinephrine in the marrow cavity of long bones.
Authors and Affiliations
Ilona Kaczmarczyk-Sedlak, Joanna Folwarczna, Urszula Cegieła, Barbara Nowińska
Keywords
Related Articles
- EP ID EP154673
- DOI -
- Views 62
- Downloads 0
Amphetamine-induced effects on neuropeptide Y in the rat brain.
Repeated (+)-amphetamine sulfate (AMPH) administration (5 mg/kg sc twicedaily for 6 days and once on day 7) markedly and reversibly decreased (until 96 h after the final dose)neuropeptide Y-like immunoreactivity (NPY-LI)...
Anxiogenic effect of CCK8s in the ventral hippocampus of rats: possible involvement of GABA(A) receptors.
Cholecystokinin (CCK) as an important neuropeptide in the brain has been implicated in the modulation of anxiety. The effects of this neurotransmitter on anxiety-like behavior in the ventral hippocampus have not been eva...
Decreased analgesic effect of morphine, but not buprenorphine, in patients with advanced P-glycoprotein(+) cancers.
Background: P-glycoprotein (P-gp) is expressed on the blood-brain barrier (BBB) and acts as a transporter regulating the analgesic effect of morphine. The P-gp is also expressed by different types of tumors. The aim of t...
MK-801, a NMDA receptor antagonist, increases phosphorylation of histone H3 in the rat medial prefrontal cortex.
Background: The present study investigated whether MK-801, when given in doses that cause psychomimetic effects in rats, could alter the phosphorylation of histone 3 (H3) at serine 10 (H3S10p) and the acetylation of H3 a...
Repeated co-treatment with fluoxetine and amantadine induces brain-derived neurotrophic factor gene expression in rats.
In the present study, we investigated the influence of repeated treatment with fluoxetine (FLU, 5 or 10 mg/kg) and amantadine (AMA, 10 mg/kg), given separately or jointly (twice daily for 14 day), at the mRNA level (the...